| abstract |
The present invention is directed to a mammal intestinal pain, or nitric oxide synthase (NOS) by administering to a patient in need thereof a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof or a prodrug thereof ) Or a condition of a mammal caused by the action of the serotonin 5HT1D / 1B receptor. The methods of the present invention also additionally include the administration of additional therapeutic agents. The invention also features a novel method of decomposing a compound of formula (I), a pharmaceutical composition thereof, and an enantiomeric mixture. |